Possis Medical AngioJet XMI-RX
This article was originally published in The Gray Sheet
Executive Summary
Rapid-exchange version of the firm's XMI Rheolytic thrombectomy catheter is approved via PMA supplement for coronary use with the firm's AngioJet system. Previously approved for peripheral use, XMI-RX also has received a CE mark for coronary use in Europe, clearing the way for its launch at the Paris Course on Revascularization meeting May 25-28. The firm expects the catheter to boost AngioJet market penetration (1"The Gray Sheet" Feb. 23, 2004, p. 21)...